Imprivata Named Best in KLAS for Identity and Access Management
Healthcare providers rate Imprivata #1 for its identity and access management platform; cite performance, ROI, value, and support for integration...
Day: February 8, 2023
BioRestorative Therapies Announces Notice of Allowance by the European Patent Office for Patent Related to its ThermoStem® Program
--Patent provides protection in key international markets for BioRestorative’s ThermoStem® program targeting obesity and metabolic disorders, including type 2 diabetes--...
LeMaitre Will Announce Fourth Quarter 2022 Earnings Results February 23, 2023
BURLINGTON, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth...
INmune Bio, Inc. Receives Approximately $6.4 Million in Research and Development Rebates from Australia and the United Kingdom
BOCA RATON, Fla., Feb. 08, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused...
Palisade Bio Promotes Robert McRae to Chief Operating Officer
Mr. McRae is an industry veteran with a proven track record of operational, clinical, and strategic business development execution Carlsbad, CA,...
IGC to be Featured in Feb. 10 Radius Research Investor Webinar
POTOMAC, Md., Feb. 08, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or...
R1 RCM & Cloudmed Ranked #1 by KLAS in Multiple Categories for 2023
Top rankings in Ambulatory RCM Services, Robotic Process Automation and Denials Management Services underscore expertise and ability to deliver complete...
Israeli- Based Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
The conference will stream live on Tuesday, February 28, at 8:30 AM EST Tel Aviv, Israel / Vancouver, Canada, Feb....
NRC Health recognized as Best in KLAS for Patient Experience Improvement
Top-ranking reinforces commitment to service and humanized care as industry standard Best in KLAS 2023 Best in KLAS Patient Experience...
Intra-Cellular Therapies to Present at the SVB Securities Global Biopharma Conference
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development...
Fortress Biotech Announces Pricing of $13.9 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
MIAMI, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused...
Inside Information: Nexstim Plc’s change negotiations have been completed
Company Announcement, Helsinki, 8 February 2023 at 3 PM (EET) Inside Information: Nexstim Plc’s change negotiations have been completed Nexstim...
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
CONSHOHOCKEN, Pa., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics...
T-knife Therapeutics Announces the Appointment of Behzad Kharabi, M.D., as Chief Medical Officer
SAN FRANCISCO and BERLIN, Feb. 08, 2023 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing...